In addition to triggering pro‐inflammatory cytokines, including IL‐6, IL‐1β, and TNFα, IL‐32 can lead to endothelial dysfunction and reduce blood levels of high‐density lipoprotein, which increases the risk of developing CVD.41 Here, IL32 is linked to endothelial dysfunction.